Case Control Study II of Genomic Markers in Menstrual Blood for Diagnosis of Uterine Disorders (H-46767)

This proposal will identify and evaluate genomic biomarkers found in menstrual fluid for the development of a non-invasive diagnostic test for uterine disorders such as endometriosis and adenomyosis, including staging and classification of disease. A non-invasive test for uterine disorders would fundamentally change how these diseases are diagnosed and treated, and it would greatly reduce the time to diagnosis, allowing for earlier interventions and better prognosis for patients with disease